Marketplace

Open

Advertisement

Marketplace

Refine Your Results

Refine Your Results

Search

Clear search

Track

+ Atherosclerosis

HDL and Triglycerides

Lipid Management

Other Atherosclerosis

Vulnerable Plaque

Complications

+ Coronary

+ ACS & AMI
Acute Coronary Syndrome Acute Myocardial Infarction Antiplatelet Therapy Antithrombotic Therapy Bleeding Complications Cardiogenic Shock Cardiovascular Pharmacology Non-STEMI Support Devices Thrombosis

CAD

+ Chronic Total Occlusion
Antegrade Devices/ wires Other Occlusion Retrograde Technique

+ Complex Coronary
Coronary Basic Lesions Subsets Others/Miscellaneous Percutaneous Devices Restenosis Women and Special Populations

COVID-19

+ Endovascular

Abdominal Aorta

Critical Limb Ischemia

Mesenteric

Neurovascular Interventions

Other Endovascular

Peripheral Vascular Interventions

Popliteal

Renal Vascular Interventions

SFA

Thoracic and Aortic Grafts

Vascular Access

Venous Disease

+ Imaging

CT Angiography

Echocardiography

Intravascular Ultrasound

Late Breaking Trials

Magnetic Resonance Imaging

Meeting and Conferences

Optical Coherence Tomography

Other Imaging

Physiologic Lesion Assessment

Positron Emission Tomography (PET)

Nurses & Technologists

+ Technology & Regulatory

Biodegradable Polymers

Biodegradable Scaffolds

Drug Coated Balloons

Drug-Eluting Stents

Emerging Devices and Innovative Therapies

FDA & regulatory topics

Meeting/Conference Archives

New Imaging Modalities

Others Technology & Innovation

Percutaneous Valve Interventions

Renal Denervation

Structural Heart Disease

+ Valve & Structural

Adult Congenital Heart Disease

Aortic Valve interventions

ASD/PFO Closure

Closure of Valvular Leaks

Imaging –Structural

Left Atrial Appendage closure

Meeting/Conferences Archives

Mitral Valve Interventions

Other Valve and Structural

Pulmonic Valve Interventions

Surgery Structural Heart Disease

Tricuspid Valve interventions

Clear selections

Type

+ Abstracts

CRT2016

CRT2017

+ Cases

CRT 2017

Cath Conferences

+ CRT Premium

2014

+ 2015
T1S00 T1S01 T2S00 T2S01 T2S02 T2S03 T2S04 T3S00 T3S01 T3S02 T3S03 T4S00 T5S00 T5S02 T5S03 T5S04 T5S05 T6S00 T6S01 T6S02 T6S03 T7S00 T7S03 T7S04 T7S05 T7S06 T7S07 T7S10 T7S11 T7S13 T7S14 T7S15 T7S21 T7S22 T7S23 T8S05

2016

+ 2017
Live Cases Monday, February 20 Saturday, February 18 Sunday, February 19 Tuesday, February 21

+ 2018
Biotronik Live Cases March 3, 2018 March 4, 2018 March 5, 2018 March 6, 2018

+ 2019
March 2, 2019 March 3, 2019 March 4, 2019 March 5, 2019

+ 2020
February 22, 2020 February 23, 2020 February 24, 2020 February 25, 2020 Protected PCI

+ 2021
April 03, 2021 April 10, 2021 April 17, 2021 April 24, 2021 April 9, 2021 February 13, 2021 February 19, 2021 February 20, 2021 February 26, 2021 February 27, 2021 June 12, 2021 June 5, 2021 March 05, 2021 March 06, 2021 March 12, 2021 March 13, 2021 March 19, 2021 March 20, 2021 March 26, 2021 March 27, 2021

+ CRT 2021 Virtual
Abstracts Interesting Cases

+ CRT Virtual Courses
December Course Fellows Course Imaging & Physiology October 24 Webinar Valve & Structural Course Women In Cardiology

Live Cases

Educational Activities

+ News

ESC2019

In the News

Trending Now/Medpage

+ Slide Presentations

+ *Meetings*
ACC AHA CRT ESC EuroPCR SCAI TCT

Cath Conference Slides

Cath Conferences SmartDocs

CRT 2018 Interesting Cases

CRT 2019 Interesting Cases

+ Interviews

+ ACC
ACC2013 ACC2014 ACC2016 ACC2018 ACC2019 ACC2021

+ AHA
AHA2014 AHA2017 AHA2018 AHA2020

COVID-19 Series

+ CRT
CRT2013 CRT2014 CRT2015 CRT2016 CRT2017 CRT2018 CRT2019 CRT2020

+ ESC
ESC 2018 ESC2013 ESC2017

+ EuroPCR
EuroPCR 2016 EuroPCR 2017 EuroPCR 2021

My Next Guest Is

+ TCT
TCT2013 TCT2014 TCT2015 TCT2016 TCT2017 TCT2018 TCT2019 TCT2020

Uploaded Videos

Clear selections

1-20 of 51 results
1 2 3

NiTiDES™ CE Mark Approval

May 31, 2021
NiTiDES™ CE Mark Approval

Public health: Stronger rules on medical devices

May 26, 2021
Public health: Stronger rules on medical devices

JenaValve Technology Receives CE Mark for its TrilogyTM TAVI System for the Treatment of Aortic Regurgitation and Aortic Stenosis

May 25, 2021 by
GLOBE NEWSWIRE

JenaValve Technology Receives CE Mark for its TrilogyTM TAVI System for the Treatment of Aortic Regurgitation and Aortic Stenosis

Real-World Data Confirms Long-Term Safety and Efficacy of BIOTRONIK’s Bioresorbable Scaffold

May 18, 2021
Real-World Data Confirms Long-Term Safety and Efficacy of BIOTRONIK’s Bioresorbable Scaffold

CeleCor Presents Clinical Trial Results of Zalunfiban (RUC-4), a Novel Platelet GPIIb/IIIa Inhibitor, in STEMI Patients

May 18, 2021 by
CeleCor Therapeutics, Inc.

CeleCor Presents Clinical Trial Results of Zalunfiban (RUC-4), a Novel Platelet GPIIb/IIIa Inhibitor, in STEMI Patients

Late-Breaking Registry Data at EuroPCR Congress Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates for the ACURATE neo2™ Aortic Valve System

May 18, 2021 by
PRNewswire

Late-Breaking Registry Data at EuroPCR Congress Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates for the ACURATE neo2™ Aortic Valve System

Abbott Receives CE Mark Approval for Next-Generation TriClip™ Device, Offering New Innovations for Tricuspid Heart Valve Repair

Apr 09, 2021
ABBOTT PARK, Ill., April 8, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark for its next-generation TriClip™ Transcatheter Tricuspid Valve Repair System, the first-of-its-kind minimally invasive tricuspid heart valve repair device available in Europe to treat tricuspid regurgitation (TR). The clip-based therapy, known as TriClip G4, is a non-surgical heart valve repair option specifically designed for the treatment of TR, or a leaky tricuspid valve, that allows physicians to tailor repair of the valve to each patient's unique anatomy.

Fluydo™ NC Approval of CE Mark

Mar 29, 2021
Fluydo™ NC Approval of CE Mark

FDA Approves First in the World Device to Treat Patients with Congenital Heart Disease

Mar 29, 2021
FDA Approves First in the World Device to Treat Patients with Congenital Heart Disease

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Mar 12, 2021 by
PRNewswire

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Medtronic Announces Voluntary Recall of Unused Valiant Navion™ Thoracic Stent Graft System

Feb 17, 2021 by
PRNewswire

Medtronic Announces Voluntary Recall of Unused Valiant Navion™ Thoracic Stent Graft System

Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease

Feb 16, 2021 by
GLOBE NEWSWIRE

Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease

The Foundry Announces Successful First-In-Human Procedure In Study Of Innovative Transcatheter Mitral Valve Repair Technology

Jan 11, 2021 by
PRNewswire

The Foundry Announces Successful First-In-Human Procedure In Study Of Innovative Transcatheter Mitral Valve Repair Technology

Pi-Cardia Successfully Treats First Patients with ShortCut™ Device

Jan 07, 2021 by
BUSINESS WIRE

Pi-Cardia Successfully Treats First Patients with ShortCut™ Device

NUI Galway coordinates “first in man” clinical trial of pioneering guidance for heart bypass surgery

Nov 25, 2020 by
NUI Galway

NUI Galway coordinates “first in man” clinical trial of pioneering guidance for heart bypass surgery

Abbott Receives CE Mark and Australian Approval for New Cardiac Mapping System

Nov 05, 2020
ABBOTT PARK, Ill., Nov. 2, 2020 — Abbott today announced it has received CE Mark and approval in Australia for its new EnSite™ X EP System, and is launching the system throughout Europe and Australia. The EnSite X System is the only system that offers the option to navigate the cardiac anatomy two different ways on one platform. Abbott sought physician feedback to develop the EnSite X System to meet current needs as well as address emerging opportunities during cardiac ablation procedures. The new cardiac mapping platform builds upon the company’s electrophysiology portfolio and is designed to improve how physicians deliver ablation therapy to treat abnormal heart rhythms.

Boston Scientific Receives FDA Approval for the Ranger™ Drug-Coated Balloon

Nov 02, 2020
Boston Scientific Receives FDA Approval for the Ranger™ Drug-Coated Balloon

Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip™ Device

Oct 30, 2020
Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip™ Device

Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX™ Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke Trial to study next-generation device as treatment

Oct 29, 2020 by
Boston Scientific

Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX™ Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation

IMPROVE Trial Enrolls First Patient

Oct 28, 2020 by
CRTonline.org

CRTonline.org

1-20 of 51 results
1 2 3

CRTonline on Facebook

CRT Meeting

CRTonline on Twitter

Tweets by CRT_meeting

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Refine Your Results

Search

Track

Type

CRTonline on Facebook

CRTonline on Twitter

Explore the Site

Stay Connected